Literature DB >> 9152297

Childhood cancer and hypercalcemia: report of a case treated with pamidronate.

M T Kutluk1, V Hazar, C Akyüz, A Varan, M Büyükpamukçu.   

Abstract

Hypercalcemia in a 4-year-old boy with non-Hodgkin lymphoma treated with pamidronate is presented. The child had relapsed disease with bone metastasis. Hypercalcemia is rare in children, and bisphosphonates are relatively new agents for the treatment of hypercalcemia. Information concerning their use in the treatment of hypercalcemia in childhood is limited. We found that pamidronate is effective and has no significant side effects in a child.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152297     DOI: 10.1016/s0022-3476(97)80030-3

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Parathyroid-hormone-related protein-mediated hypercalcemia in benign congenital mesoblastic nephroma.

Authors:  Tarak Srivastava; Alexander Kats; T John Martin; Suelli Pompolo; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2010-12-15       Impact factor: 3.714

2.  Addition of pamidronate to chemotherapy for the treatment of osteosarcoma.

Authors:  Paul A Meyers; John H Healey; Alexander J Chou; Leonard H Wexler; Pamela R Merola; Carol D Morris; Michael P Laquaglia; Michael G Kellick; Sara J Abramson; Richard Gorlick
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

3.  Pamidronate in a girl with chronic renal insufficiency dependent on parenteral nutrition.

Authors:  Janet L Duke; Deborah P Jones; Noel K Frizzell; Russell W Chesney; Emily B Hak
Journal:  Pediatr Nephrol       Date:  2003-05-15       Impact factor: 3.714

4.  The Current and Future Therapies for Human Osteosarcoma.

Authors:  Joseph D Lamplot; Sahitya Denduluri; Jiaqiang Qin; Ruidong Li; Xing Liu; Hongyu Zhang; Xiang Chen; Ning Wang; Abdullah Pratt; Wei Shui; Xiaoji Luo; Guoxin Nan; Zhong-Liang Deng; Jinyong Luo; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Curr Cancer Ther Rev       Date:  2013-02

Review 5.  The role of bisphosphonates in diseases of childhood.

Authors:  Tarak Srivastava; Uri S Alon
Journal:  Eur J Pediatr       Date:  2003-09-11       Impact factor: 3.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.